Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...

Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 ...

HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines.

On Tuesday, Citi analyst Michael Rollins adjusted the price target for Cogent Communications (NASDAQ: CCOI) stock, reducing it from $82.00 to $67.00, yet reaffirming a Buy rating.The revision follows ...

They currently have a $8.00 target price on the stock. A number of other research firms also recently issued reports on GANX. Chardan Capital reaffirmed a “buy” rating and set a $6.00 price ...

“That said, reworking the way Americans buy their medicine is going to take a long time. Along the way, efforts to support direct-to-consumer sales will support both the manufacturers leading ...

On May 15, Christopher Danely from Citi maintained a “Buy” rating on the stock with a price target of $110.00. A few days prior, J.P. Morgan analyst Harlan Sur maintained their bullish stance ...

MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price ...

Getty Images Shares of Affirm rose Wednesday after the company announced a deal to make its buy now, pay later services ... The recent rise in Affirm's shares has the stock trading at above ...